Key points are not available for this paper at this time.
Highlights•Chemotherapy-induced neutropenia can lead to poor clinical outcomes.•CIN can lead to infections, hospitalizations, mortality, and lower chemotherapy dose intensity.•G-CSF agents have been the standard of care for the prevention of CIN for 30 years.•Emerging therapies will likely change the standard approach for CIN prevention.
Blayney et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: